The Bengal Bite 🐯 | Cannabis Disruption | June 12, 2020
A global pandemic has “disrupted” the world. In many cases, COVID has been a catalyst to accelerate change that was already in progress. Momentum behind “cannabis disruption” has been building for years, and the industry is on the verge of causing major disruption to numerous multibillion-dollar industries. Cannabis has already made inroads into the $65 billion+ pain management category as patients opt for medical marijuana instead of opioids and senior citizens utilize THC inhalers and cannabis balms to manage arthritis and other chronic pain. As research unlocks novel uses of cannabis, billions of dollars of health & wellness, pharma, alcohol & beverage, and cosmetics market share is in play.
The Bengal Capital Team
Researchers say access to medical marijuana might help cut down on opioid use
“A recent study published in the Journal of the American Academy of Orthopedic Surgeons this month suggests that the availability of medical marijuana has been responsible for an almost 20% drop in the number of opioids prescriptions written.” Read more on this study in Forbes by clicking here.
Can cannabis inhalers provide effective treatment for chronic pain?
A study led by a team of Israeli scientists found precise doses of THC administered via inhaler were effective in reducing pain in neuropathy patients while avoiding combustion and impairment in cognitive performance. Read more on how this form factor is disrupting pain management in Benzinga here.
Formerly anti-legalization Massachusetts lawmakers vie for marijuana vote in senate primary debate
Demonstrating how cannabis legalization has disrupted societal norms, both candidates in the Democratic U.S. Senate primary in Massachusetts are vying to be the choice for the pro-cannabis electorate. Read more about their debate on the Marijuana Moment here.
Was quarantine made for cannabis?
“We get to provide a little relief to a stressed society.” As more people become familiar with the therapeutic, anti-anxiety benefits of cannabis, the $15 billion+ anxiety relief/management category is on notice. Read more on how some are managing stress with cannabis during quarantine in the New Yorker here.